Citations

Citations to this article as recorded by  

• How was the Diabetes Metabolism Journal added to MEDLINE?
  Hye Jin Yoo
  Science Editing.2020; 7(2): 201.     CrossRef

The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously in this group until more definitive evidence concerning its safety is available. The Korean Diabetes Association and the Korean Society of Nephrology have agreed on consensus statements concerning metformin use for patients with T2DM and renal dysfunction, particularly when these patients undergo imaging studies using iodinated contrast media (ICM). Metformin can be used safely when the estimated glomerular filtration rate (eGFR) is ≥45 mL/min/1.73 m². If the eGFR is between 30 and 44 mL/min/1.73 m², metformin treatment should not be started. If metformin is already in use, a daily dose of ≤1,000 mg is recommended. Metformin is contraindicated when the eGFR is <30 mL/min/1.73 m². Renal function should be evaluated prior to any ICM-related procedures. During procedures involving intravenous administration of ICM, metformin should be discontinued starting the day of the procedures and up to 48 hours post-procedures if the eGFR is <60 mL/min/1.73 m².

Citations

Citations to this article as recorded by  

• Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study
  Wonjoon Jeong, Jung Sunwoo, Yeonho You, Jung Soo Park, Jin Hong Min, Yong Nam In, Hong Joon Ahn, So Young Jeon, Jang Hee Hong, Ji Hye Song, Hyein Kang, My Tuyen Thi Nguyen, Jaehan Kim, Changshin Kang
  Scientific Reports.2024;[Epub]     CrossRef
• Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication
  Alisher Ikramov, Shakhnoza Mukhtarova, Raisa Trigulova, Dilnoza Alimova, Saodat Abdullaeva
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Clinical Management of Type II DM in patients Showing Progressive Increase in the Creatinine Level – A Cross-sectional Study
  Prabhudatta Mohapatra, Durga Madhab Kar, Karmajeet Rath, Abhisek Pal
  Research Journal of Pharmacy and Technology.2024; : 2719.     CrossRef
• Determinants of vitamin B12 deficiency in patients with type-2 diabetes mellitus — A primary-care retrospective cohort study
  Andrew Kien Han Wee, Rehena Sultana
  BMC Primary Care.2023;[Epub]     CrossRef
• Risk factors for post-contrast acute kidney injury in patients sequentially administered iodine- and gadolinium-based contrast media on the same visit to the emergency department: a retrospective study
  Changshin Kang, Soo Hyun Han, Jung Soo Park, Dae Eun Choi
  Kidney Research and Clinical Practice.2023; 42(3): 358.     CrossRef
• Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia
  Mohammad E. Khamseh, Mojtaba Malek, Nahid Hashemi-madani, Fariba Ghassemi, Neda Rahimian, Amir Ziaee, Mohammad Reza Foroughi-Gilvaee, Pooya Faranoush, Negin Sadighnia, Ali Elahinia, Mohammad Reza Rezvany, Mohammad Faranoush
  Iranian Journal of Blood and Cancer.2023; 15(4): 293.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future
  Filipe Ferrari, Rafael S. Scheffel, Vítor M. Martins, Raul D. Santos, Ricardo Stein
  American Journal of Cardiovascular Drugs.2022; 22(4): 363.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis
  Ting-Wan Kao, Kuo-Hua Lee, Wing P. Chan, Kang-Chih Fan, Che-Wei Liu, Yu-Chen Huang
  European Radiology.2021; 32(5): 3045.     CrossRef
• Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
  Eugene Han, Hye Soon Kim
  Diabetes & Metabolism Journal.2021; 45(6): 972.     CrossRef
• KRCP's past and future path
  Tae-Hyun Yoo
  Kidney Research and Clinical Practice.2020; 39(3): 233.     CrossRef
• Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
  Yao Hu, Min Lei, Guibao Ke, Xin Huang, Xuan Peng, Lihui Zhong, Ping Fu
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Pharmacotherapy for patients with diabetes mellitus
  Joon Ho Moon, Soo Lim
  Journal of the Korean Medical Association.2020; 63(12): 766.     CrossRef

The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM) are overweight/obese, which increases the risk of cardiorenal outcomes in these patients; hence, sustained reductions in body weight and visceral adiposity are important management goals. However, most of the glucose-lowering therapies such as insulin, sulfonylureas, glinides, and thiazolidinediones induce weight gain, which makes the management of overweight/obese T2DM patients challenging. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are the only oral glucose-lowering agents that have been shown to reduce body weight and visceral adiposity. In addition, SGLT-2 inhibitors therapy reduces ectopic fat deposition and improves adipose tissue function and weight-related quality of life. In this article, we aim to consolidate the existing literature on the effects of SGLT-2 inhibitors in Asian patients with T2DM and to produce clinical recommendations on their use in overweight or obese patients with T2DM. Recommendations from international and regional guidelines, as well as published data from clinical trials in Asian populations and cardiovascular outcomes trials are reviewed. Based on the available data, SGLT-2 inhibitors represent an evidence-based therapeutic option for the management of overweight/obese patients with T2DM.

Citations

Citations to this article as recorded by  

• The interaction between non-coding RNAs and SGLT2: A review
  Joanna Jarosz-Popek, Ceren Eyileten, Gloria M. Gager, Anna Nowak, Piotr Szwed, Zofia Wicik, Jeff Palatini, Dirk von Lewinski, Harald Sourij, Jolanta M. Siller-Matula, Marek Postula
  International Journal of Cardiology.2024; 398: 131419.     CrossRef
• A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study
  Tae Seo Sohn, Kyung‐Ah Han, Yonghyun Kim, Byung‐Wan Lee, Suk Chon, In‐Kyung Jeong, Eun‐Gyoung Hong, Jang Won Son, JaeJin Na, Jae Min Cho, Seong In Cho, Wan Huh, Kun‐Ho Yoon
  Diabetes, Obesity and Metabolism.2024; 26(6): 2248.     CrossRef
• Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus
  Seyed Saman Talebi, Shabnam Rezaie, Minoo Sadat Hajmiri, Maryam Zamanirafe, Akram Ranjbar, Heresh Moridi, Mahtabalsadat Mirjalili, Maryam Mehrpooya
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024;[Epub]     CrossRef
• Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial
  Soo Heon Kwak, Kyung Ah Han, Eun Sook Kim, Sung Hee Choi, Jong Chul Won, Jae Myung Yu, Seungjoon Oh, Hye Jin Yoo, Chong Hwa Kim, Kyung‐Soo Kim, SungWan Chun, Yong Hyun Kim, Seung Ah Cho, Da Hye Kim, Kyong Soo Park
  Diabetes, Obesity and Metabolism.2024; 26(10): 4203.     CrossRef
• The effect of combining nutrient intake and physical activity levels on central obesity, sarcopenia, and sarcopenic obesity: a population-based cross-sectional study in South Korea
  Jong Eun Park, Seulgi Lee, Kirang Kim
  BMC Geriatrics.2023;[Epub]     CrossRef
• Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
  Minyoung Lee, Kyeongseob Jeong, Yu Rang Park, Yumie Rhee
  Metabolism.2023; 138: 155311.     CrossRef
• Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
  Leili Gao, Zhifeng Cheng, Benli Su, Xiuhai Su, Weihong Song, Yushan Guo, Lin Liao, Xiaowen Chen, Jiarui Li, Xingrong Tan, Fangjiang Xu, Shuguang Pang, Kun Wang, Jun Ye, Yuan Wang, Lili Chen, Jingfang Sun, Linong Ji
  Diabetes, Obesity and Metabolism.2023; 25(3): 785.     CrossRef
• Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
  Bains Jasleen, Gupta K Vishal, Malepati Sameera, Molla Fahad, O'Brien Brendan, Santander Deion, Sudhakar Pemminati
  Cureus.2023;[Epub]     CrossRef
• Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance
  Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won
  Diabetes & Metabolism Journal.2023; 47(1): 82.     CrossRef
• Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
  Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B. Cater, Robert Frederich
  Diabetes Therapy.2023; 14(2): 319.     CrossRef
• Research Progress of Dapagliflozin in Treatment of Acute Myocardial Infarction Complicated with Type 2 Diabetes Mellitus
  鸿 王
  Advances in Clinical Medicine.2023; 13(02): 1667.     CrossRef
• Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis
  Hye Jin Chun, Eun Ran Kim, Minyoung Lee, Da Hyun Choi, Soo Hyun Kim, Eugene Shin, Jin-Hong Kim, Jin Won Cho, Dai Hoon Han, Bong-Soo Cha, Yong-ho Lee
  Metabolism.2023; 145: 155612.     CrossRef
• Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
  Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho Yoon
  Diabetes & Metabolism Journal.2023; 47(6): 796.     CrossRef
• Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns
  Buchun Jiang, Zhiwen Cheng, Fei Liu, Qiuyu Li, Haidong Fu, Jianhua Mao
  Nephrology.2022; 27(2): 126.     CrossRef
• Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
  Angelo Cignarelli, Valentina Annamaria Genchi, Giulia Le Grazie, Irene Caruso, Nicola Marrano, Giuseppina Biondi, Rossella D’Oria, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Liraglutide Alleviates Diabetic Atherosclerosis through Regulating Calcification of Vascular Smooth Muscle Cells
  Li-Li Shi, Ming Hao, Zhou-Yun Jin, Gui-Fang Peng, Ying-Ying Tang, Hong-Yu Kuang, Yaoyao Bian
  Disease Markers.2022; 2022: 1.     CrossRef
• Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study
  Rongfeng Han, Yang Zhang, Xia Jiang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1461.     CrossRef
• The dual role of empagliflozin: Cardio renal protection in T2DM patients
  Aimen Shafiq, Eman Mahboob, Muhammad Ammar Samad, Mohammad Hassam Ur Rehman, Zoaib Habib Tharwani
  Annals of Medicine & Surgery.2022;[Epub]     CrossRef
• Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy?
  Katarzyna Wołos-Kłosowicz, Wojciech Matuszewski, Joanna Rutkowska, Katarzyna Krankowska, Elżbieta Bandurska-Stankiewicz
  Journal of Clinical Medicine.2022; 11(20): 6183.     CrossRef
• Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development
  Ernest A. Adeghate, Huba Kalász, Saeeda Al Jaberi, Jennifer Adeghate, Kornelia Tekes
  Expert Opinion on Investigational Drugs.2021; 30(2): 85.     CrossRef
• Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
  Jianping Weng, Longyi Zeng, Yuwei Zhang, Shen Qu, Xueying Wang, Ping Li, Liujun Fu, Boqing Ma, Shandong Ye, Jiao Sun, Weiping Lu, Zhiwen Liu, Daoxiong Chen, Zhifeng Cheng, Haiyan Liu, Tao Zhang, Jianjun Zou
  Diabetes, Obesity and Metabolism.2021; 23(8): 1754.     CrossRef
• How do you treat obesity in the elderly pharmacologically?
  Claudio Daniel González, Guillermo Di Girolamo
  Expert Opinion on Pharmacotherapy.2021; 22(13): 1639.     CrossRef
• Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
  Ayako Nagayama, Kenji Ashida, Miki Watanabe, Kanoko Moritaka, Aya Sonezaki, Yoichiro Kitajima, Hirokazu Takahashi, Satoko Yoshinobu, Shimpei Iwata, Junichi Yasuda, Nao Hasuzawa, Shuichi Ozono, Seiichi Motomura, Masatoshi Nomura
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• New Pandemic: Obesity and Associated Nephropathy
  Isha Sharma, Yingjun Liao, Xiaoping Zheng, Yashpal S. Kanwar
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
  Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro
  Diabetes Research and Clinical Practice.2021; 180: 109067.     CrossRef
• The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
  Mariana Tilinca, Robert Tiuca, Ioan Tilea, Andreea Varga
  Journal of Personalized Medicine.2021; 11(12): 1249.     CrossRef
• Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
  Wayne H‐H Sheu
  Journal of Diabetes Investigation.2020; 11(5): 1115.     CrossRef

• SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients

  
  André J Scheen
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 2765.     CrossRef
• SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
  Yoshifumi Saisho
  Diseases.2020; 8(2): 14.     CrossRef
• Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis　― An Update on Recent Findings ―
  Kimie Tanaka, Daiju Fukuda, Masataka Sata
  Circulation Journal.2020; 85(1): 2.     CrossRef

Mitochondrial medicine is increasingly discussed as a promising therapeutic approach, given that mitochondrial defects are thought to contribute to many prevalent diseases and their complications. In individuals with diabetes mellitus (DM), defects in mitochondrial structure and function occur in many organs throughout the body, contributing both to the pathogenesis of DM and complications of DM. Diabetic cardiomyopathy (DbCM) is increasingly recognized as an underlying cause of increased heart failure in DM, and several mitochondrial mechanisms have been proposed to contribute to the development of DbCM. Well established mechanisms include myocardial energy depletion due to impaired adenosine triphosphate (ATP) synthesis and mitochondrial uncoupling, and increased mitochondrial oxidative stress. A variety of upstream mechanisms of impaired ATP regeneration and increased mitochondrial reactive oxygen species have been proposed, and recent studies now also suggest alterations in mitochondrial dynamics and autophagy, impaired mitochondrial Ca²⁺ uptake, decreased cardiac adiponectin action, increased O-GlcNAcylation, and impaired activity of sirtuins to contribute to mitochondrial defects in DbCM, among others. In the current review, we present and discuss the evidence that underlies both established and recently proposed mechanisms that are thought to contribute to mitochondrial dysfunction in DbCM.

Citations

Citations to this article as recorded by  

• SIRT1: a promising therapeutic target in type 2 diabetes mellitus
  Ainaz Mihanfar, Maryam Akbarzadeh, Saber Ghazizadeh Darband, Shirin Sadighparvar, Maryam Majidinia
  Archives of Physiology and Biochemistry.2024; 130(1): 13.     CrossRef
• Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy
  Feng Zhang, Jian jian Lin, Hao nan Tian, Jun Wang
  Experimental Physiology.2024; 109(2): 190.     CrossRef
• Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
  Chennian Xu, Lin Xia, Dengyue Xu, Yang Liu, Ping Jin, Mengen Zhai, Yu Mao, Yiwei Wang, Anguo Wen, Jian Yang, Lifang Yang
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Mitochondrial dynamics and the significance of its disturbances in the development of childhood diseases. Part II. Cardiological and endocrinological aspects
  V. S. Sukhorukov, T. I. Baranich, A. V. Egorova, E. N. Fedorova, K. A. Skvortsova, D. A. Kharlamov, A. I. Krapivkin
  Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics).2024; 69(2): 12.     CrossRef
• Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
  Pan Liu, Zhengdong Zhang, Yichen Cai, Zhaoying Li, Qian Zhou, Qiu Chen
  Ageing Research Reviews.2024; 94: 102201.     CrossRef
• Salidroside Alleviates Myocardial Ischemia Reperfusion by Balancing Mitochondrial Homeostasis via Nrf2
  Tingxu Yan, Xu Li, Xin Wang, Bosai He, Ying Jia, Wei Xiao, Rong He
  Journal of Food Biochemistry.2024; 2024: 1.     CrossRef
• AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
  Jiabing Zhan, Kunying Jin, Rong Xie, Jiahui Fan, Yuyan Tang, Chen Chen, Huaping Li, Dao Wen Wang
  Circulation.2024; 149(14): 1102.     CrossRef
• Pathophysiological aspects of morphological changes in the structure of atrioventricular valves leafl ets in diabetes mellitus
  V. V. Krylov, M. R. Ragimov, I. V. Misnikova
  Clinical Medicine (Russian Journal).2024; 102(2): 109.     CrossRef
• Promoting mitochondrial dynamics by inhibiting the PINK1–PRKN pathway to relieve diabetic nephropathy
  Jun-yi Zhu, Joyce van de Leemput, Zhe Han
  Disease Models & Mechanisms.2024;[Epub]     CrossRef
• SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
  Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
  Cardiovascular Research.2024; 120(5): 443.     CrossRef
• Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
  Maria Antonietta Riemma, Elena Mele, Maria Donniacuo, Marialucia Telesca, Gabriella Bellocchio, Giuseppe Castaldo, Francesco Rossi, Antonella De Angelis, Donato Cappetta, Konrad Urbanek, Liberato Berrino
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice
  Qingyu Huang, Tongqing Chen, Jian Li, Yiming Wang, Huairui Shi, Yifei Yu, Qingwei Ji, Xiaoyan Shen, Tao Sun, Haiming Shi, Xinping Luo, Bo Jin, Yan You, Bangwei Wu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Lysophosphatidylcholine trigger myocardial injury in diabetic cardiomyopathy via the TLR4/ZNF480/AP-1/NF-kB pathway
  Nannan Liu, Yang Chen, Tian An, Siyu Tao, Bohan Lv, Jinfang Dou, Ruxue Deng, Xianjie Zhen, Yuelin Zhang, Caizhong Lu, Zhongsheng Chang, Guangjian Jiang
  Heliyon.2024; 10(13): e33601.     CrossRef
• Improvement of Cardiac Function and Subcellular Defects Due to Chronic Diabetes upon Treatment with Sarpogrelate
  Paramjit S. Tappia, Vijayan Elimban, Anureet K. Shah, Ramesh K. Goyal, Naranjan S. Dhalla
  Journal of Cardiovascular Development and Disease.2024; 11(7): 215.     CrossRef
• Progress of Mitochondrial Kinetics in Ejection Fraction Preserving Heart Failure
  梦茹 胡
  Advances in Clinical Medicine.2024; 14(07): 945.     CrossRef
• Molecular Basis of Cardiomyopathies in Type 2 Diabetes
  Silvia Giardinelli, Giovanni Meliota, Donatella Mentino, Gabriele D’Amato, Maria Felicia Faienza
  International Journal of Molecular Sciences.2024; 25(15): 8280.     CrossRef
• Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling
  Warisara Parichatikanond, Sudhir Pandey, Supachoke Mangmool
  Biochemical Pharmacology.2024; 229: 116552.     CrossRef
• Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
  Jing Wang, Haojie Xue, Jinyu He, Li Deng, Julong Tian, Yang Jiang, Jian Feng
  Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
• Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
  Ren Jie Phang, Rebecca H Ritchie, Derek J Hausenloy, Jarmon G Lees, Shiang Y Lim
  Cardiovascular Research.2023; 119(3): 668.     CrossRef
• Mitochondrial miRNA as epigenomic signatures: Visualizing aging-associated heart diseases through a new lens
  Jasvinder Singh Bhatti, Naina Khullar, Rajesh Vijayvergiya, Umashanker Navik, Gurjit Kaur Bhatti, P. Hemachandra Reddy
  Ageing Research Reviews.2023; 86: 101882.     CrossRef
• Eucommiae Folium and Active Compounds Protect Against Mitochondrial Dysfunction-Calcium Overload in Epileptic Hippocampal Neurons Through the Hypertrophic Cardiomyopathy Pathway
  Shuai-nan Zhang, Hong-mei Li, Qi Liu, Xu-zhao Li, Wu-de Yang, Ying Zhou
  Neurochemical Research.2023; 48(9): 2674.     CrossRef
• Speckle-tracking echocardiography provides sensitive measurements of subtle early alterations associated with cardiac dysfunction in T2DM rats
  Yanchao Qi, Zhiyan Chen, Bingyan Guo, Zhe Liu, Lijie Wang, Suyun Liu, Lixiang Xue, Meifang Ma, Yajuan Yin, Yongjun Li, Gang Liu
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments
  Fumin Zhi, Qian Zhang, Li Liu, Xing Chang, Hongtao Xu
  Cell Stress and Chaperones.2023; 28(6): 641.     CrossRef
• Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury
  Weixing Wen, Haoxiao Zheng, Weiwen Li, Guolin Huang, Peng Chen, Xiaolin Zhu, Yue Cao, Jiahuan Li, Xiaohui Huang, Yuli Huang
  Metabolism.2023; 147: 155662.     CrossRef
• Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference
  Panpan Liu, Zhuli Yang, Youjun Wang, Aomin Sun
  International Journal of Molecular Sciences.2023; 24(17): 13188.     CrossRef
• Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
  Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, Marco Fiorillo, Francesco Moccia, Giuseppe Viglietto, Tommaso Angelone, Nicola Amodio
  Journal of Translational Medicine.2023;[Epub]     CrossRef
• Triarylphosphonium compounds as effective vectors for mitochondria-targeted delivery systems: decoration strategies and prospects for clinical application
  T. N. Pashirova, A. V. Nemtarev, E. B. Souto, V. F. Mironov
  Russian Chemical Reviews.2023; 92(10): RCR5095.     CrossRef
• Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
  Sarah D’Haese, Maxim Verboven, Lize Evens, Dorien Deluyker, Ivo Lambrichts, BO Eijnde, Dominique Hansen, Virginie Bito
  Nutrients.2023; 15(18): 3950.     CrossRef
• Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury
  Sanaz Gholami, Reza Badalzadeh, Alireza Alihemmati
  Canadian Journal of Physiology and Pharmacology.2023; 101(12): 682.     CrossRef
• Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
  Qutuba G Karwi, Kim L Ho, Simran Pherwani, Ezra B Ketema, Qiuyu Sun, Gary D Lopaschuk
  Cardiovascular Research.2022; 118(3): 686.     CrossRef
• Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy
  Carolina Jaquenod De Giusti, Julieta Palomeque, Alicia Mattiazzi
  Pflügers Archiv - European Journal of Physiology.2022; 474(1): 33.     CrossRef
• Double-edge sword roles of iron in driving energy production versus instigating ferroptosis
  Shuping Zhang, Wei Xin, Gregory J. Anderson, Ruibin Li, Ling Gao, Shuguang Chen, Jiajun Zhao, Sijin Liu
  Cell Death & Disease.2022;[Epub]     CrossRef
• Differential remodelling of mitochondrial subpopulations and mitochondrial dysfunction are a feature of early stage diabetes
  Bodour S. Rajab, Sarah Kassab, Connor D. Stonall, Hussam Daghistani, Stephen Gibbons, Mamas Mamas, David Smith, Aleksandr Mironov, Zainab AlBalawi, Yin Hua Zhang, Florence Baudoin, Min Zi, Sukhpal Prehar, Elizabeth J. Cartwright, Ashraf Kitmitto
  Scientific Reports.2022;[Epub]     CrossRef
• GlyNAC (Glycine and N-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study
  Rajagopal V. Sekhar
  Antioxidants.2022; 11(1): 154.     CrossRef
• Glucose-derived posttranslational modification in cardiovascular disease
  Michael Lehrke, Julia Moellmann, Florian Kahles, Nikolaus Marx
  Molecular Aspects of Medicine.2022; 86: 101084.     CrossRef
• Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
  Anastasia V. Poznyak, Tatiana V. Kirichenko, Evgeny E. Borisov, Nikolay K. Shakhpazyan, Andrey G. Kartuesov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(6): 2951.     CrossRef
• Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction
  Shanhu Qiu, Jianhua Ma, Tongzhi Wu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Alternative autophagy: mechanisms and roles in different diseases
  Hong Feng, Nian Wang, Nan Zhang, Hai-han Liao
  Cell Communication and Signaling.2022;[Epub]     CrossRef
• Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
  Siarhei A. Dabravolski, Alexander D. Zhuravlev, Andrey G. Kartuesov, Evgeny E. Borisov, Vasily N. Sukhorukov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(10): 5371.     CrossRef
• Animal Models of Dysregulated Cardiac Metabolism
  Heiko Bugger, Nikole J. Byrne, E. Dale Abel
  Circulation Research.2022; 130(12): 1965.     CrossRef
• Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease
  Jianguo Lin, Jinlong Duan, Qingqing Wang, Siyu Xu, Simin Zhou, Kuiwu Yao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids
  Ronghui Han, Hemeng Huang, Weiyi Xia, Jingjin Liu, Hui Luo, Jing Tang, Zhengyuan Xia
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
  Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, Anemut Tilahun Mulu, Assefa Agegnehu Teshome, Edgeit Abebe Zewde, Zelalem Tilahun Muche, Muluken Teshome Azezew
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effect of Chronic Treatment with Uridine on Cardiac Mitochondrial Dysfunction in the C57BL/6 Mouse Model of High-Fat Diet–Streptozotocin-Induced Diabetes
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Maxim N. Belosludtsev, Mikhail V. Dubinin, Galina D. Mironova, Konstantin N. Belosludtsev
  International Journal of Molecular Sciences.2022; 23(18): 10633.     CrossRef
• FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
  Leigang Jin, Leiluo Geng, Lei Ying, Lingling Shu, Kevin Ye, Ranyao Yang, Yan Liu, Yao Wang, Yin Cai, Xue Jiang, Qin Wang, Xingqun Yan, Boya Liao, Jie Liu, Fuyu Duan, Gary Sweeney, Connie Wai Hong Woo, Yu Wang, Zhengyuan Xia, Qizhou Lian, Aimin Xu
  Circulation.2022; 146(20): 1537.     CrossRef
• Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
  Jing Bai, Chuanbin Liu, Pingjun Zhu, Yang Li
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
  Khalil Saadeh, Ibrahim Talal Fazmin
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
  Fan Ying, Hao Liu, Eva Hoi Ching Tang, Ishan Lakhani, Ningning Liu, Zhengyuan Xia, Shiming Liu
  Biochemical and Biophysical Research Communications.2021; 548: 196.     CrossRef
• Study of long non-coding RNA and mitochondrial dysfunction in diabetic rats
  Haytham K. Sultan, Wael M. El-Ayat, Azza H. AbouGhalia, Noha N. Lasheen, Amr S. Moustafa
  Tissue and Cell.2021; 71: 101516.     CrossRef
• A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates
  Xiu Wang, Shi Jin, Weina Hu, Gaetano Santulli
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy
  Uzair Ahmed, Usman Ali Ashfaq, Muhammad Qasim, Imtiaz Ahmad, Hafiz Usman Ahmad, Muhammad Tariq, Muhammad Shareef Masoud, Saba Khaliq, Muhammad Younas Khan Barozai
  PLOS ONE.2021; 16(4): e0250773.     CrossRef
• MicroRNAs Regulating Mitochondrial Function in Cardiac Diseases
  Guang-Qiong Zhang, Sheng-Quan Wang, Yan Chen, Ling-Yun Fu, Yi-Ni Xu, Ling Li, Ling Tao, Xiang-Chun Shen
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway
  Salma M. Eraky, Nehal M. Ramadan
  The Journal of Nutritional Biochemistry.2021; 97: 108798.     CrossRef
• Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
  Mao Liu, Jiao Ai, Zhuang Shuai, Kai Tang, Zongyu Li, Yin Huang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
  Izabela Tuleta, Nikolaos G. Frangogiannis
  Advanced Drug Delivery Reviews.2021; 176: 113904.     CrossRef
• Effect of the MPT Pore Inhibitor Alisporivir on the Development of Mitochondrial Dysfunction in the Heart Tissue of Diabetic Mice
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Dmitriy A. Serov, Maxim E. Astashev, Maxim N. Belosludtsev, Mikhail V. Dubinin, Konstantin N. Belosludtsev
  Biology.2021; 10(9): 839.     CrossRef
• Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
  Alex M. Parker, Mitchel Tate, Darnel Prakoso, Minh Deo, Andrew M. Willis, David M. Nash, Daniel G. Donner, Simon Crawford, Helen Kiriazis, Cesare Granata, Melinda T. Coughlan, Miles J. De Blasio, Rebecca H. Ritchie
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Radiation‑induced dysfunction of energy metabolism in the heart results in the fibrosis of cardiac tissues
  Peng Xu, Yali Yi, Yijing Luo, Zhicheng Liu, Yilin Xu, Jing Cai, Zhimin Zeng, Anwen Liu
  Molecular Medicine Reports.2021;[Epub]     CrossRef
• Heart Failure and Diabetes: Perspective of a Dangerous Association
  Liliana E. Favaloro, Roxana D. Ratto, Carla Musso
  Current Hypertension Reviews.2021; 17(2): 85.     CrossRef
• CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response
  Bernd Niemann, Ling Li, Dorothee Siegler, Benedikt H. Siegler, Fabienne Knapp, Jakob Hanna, Muhammad Aslam, Michael Kracht, Rainer Schulz, Susanne Rohrbach
  Cells.2020; 9(5): 1229.     CrossRef
• The Hippo Pathway Orchestrates Mitochondrial Quality Control: A Novel Focus on Cardiovascular Diseases
  Ying Tan, Cai Lei, Huifang Tang, Xiao Zhu, Guanghui Yi
  DNA and Cell Biology.2020; 39(9): 1494.     CrossRef
• Adeno-Associated Viral Transfer of Glyoxalase-1 Blunts Carbonyl and Oxidative Stresses in Hearts of Type 1 Diabetic Rats
  Fadhel A. Alomar, Abdullah Al-Rubaish, Fahad Al-Muhanna, Amein K. Al-Ali, JoEllyn McMillan, Jaipaul Singh, Keshore R. Bidasee
  Antioxidants.2020; 9(7): 592.     CrossRef
• Loss of function of transcription factor EB remodels lipid metabolism and cell death pathways in the cardiomyocyte
  Purvi C. Trivedi, Jordan J. Bartlett, Angella Mercer, Logan Slade, Marc Surette, Andrea Ballabio, Stephane Flibotte, Bahira Hussein, Brian Rodrigues, Petra C. Kienesberger, Thomas Pulinilkunnil
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(10): 165832.     CrossRef
• Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol
  Matthew Kerr, Jack J. Miller, Dharendra Thapa, Sophie Stiewe, Kerstin N. Timm, Claudia N. Montes Aparicio, Iain Scott, Damian J. Tyler, Lisa C. Heather
  JCI Insight.2020;[Epub]     CrossRef
• Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
  Konstantin N. Belosludtsev, Natalia V. Belosludtseva, Mikhail V. Dubinin
  International Journal of Molecular Sciences.2020; 21(18): 6559.     CrossRef
• Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes
  Rocchina Vilella, Gianluca Sgarbi, Valeria Naponelli, Monia Savi, Leonardo Bocchi, Francesca Liuzzi, Riccardo Righetti, Federico Quaini, Caterina Frati, Saverio Bettuzzi, Giancarlo Solaini, Donatella Stilli, Federica Rizzi, Alessandra Baracca
  Nutrients.2020; 12(10): 2949.     CrossRef
• Diabetic cardiomyopathy: definition, diagnosis criteria, treatment directions and prevention of heart failure
  N. A. Koziolova, P. G. Karavaev, A. S. Veklich
  South Russian Journal of Therapeutic Practice.2020; 1(2): 93.     CrossRef
• Adiponectin protects HL-1 cardiomyocytes against rotenone-induced cytotoxicity through AMPK activation
  Biao Li, Baojian Zhang, Na Liu, Keke Wu, Yingxu Ma, Wanyun Zuo, Zuodong Ning, Yaozhong Liu, Chao Sun, Yichao Xiao, Tao Tu, Qiming Liu
  Toxicology Letters.2020; 335: 82.     CrossRef
• Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
  Nicholas Esch, Seokwon Jo, Mackenzie Moore, Emilyn U. Alejandro, Yingke Xu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
  Ehtasham Ahmad, Jack Sargeant, Francesco Zaccardi, Kamlesh Khunti, David Webb, Melanie Davies
  Pharmaceuticals.2020; 13(12): 427.     CrossRef

Citations

Citations to this article as recorded by  

• What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review
  Xiaokun Lou, Yuanyuan Zhang, Junfeng Guo, Lina Gao, Yingying Ding, Xinyu Zhuo, Qingqing Lei, Jing Bian, Rumei Lei, Wenyan Gong, Xingwei Zhang, Qibin Jiao
  Heart Failure Reviews.2023; 29(1): 1.     CrossRef
• MiR-29a regulates cardiomyocyte apoptosis by targeting Bak1 in diabetic cardiomyopathy
  Xiaoyan Wang, Zhitao Zhang, Mei Wang
  The Journal of Biochemistry.2022; 171(6): 663.     CrossRef

Citations

Citations to this article as recorded by  

• Response: An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment (Diabetes Metab J 2020;44:56–66)
  Sung Woon Park, Seunghyun Lee, Won Chul Cha, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Sung-Min Park, Sang-Man Jin
  Diabetes & Metabolism Journal.2020; 44(2): 358.     CrossRef
• Letter: An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment (Diabetes Metab J 2020;44:56–66)
  Dongwon Yi
  Diabetes & Metabolism Journal.2020; 44(2): 354.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
  Ji-Yeon Park, Joonyub Lee, Yoon-Hee Choi, Kyung Wan Min, Kyung Ah Han, Kyu Jeung Ahn, Soo Lim, Young-Hyun Kim, Chul Woo Ahn, Kyung Mook Choi, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2024; 48(5): 915.     CrossRef
• Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study
  Yun Kyung Cho, Kyung-Soo Kim, Byung-Wan Lee, Jun Hwa Hong, Jae Myung Yu, Soo Lim, Ye An Kim, Chang Beom Lee, Sang Soo Kim, Soo Heon Kwak, Woo Je Lee
  Clinical Therapeutics.2024; 46(9): 662.     CrossRef
• Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
  Ji Hye Heo, Kyung Ah Han, Jun Hwa Hong, Hyun-Ae Seo, Eun-Gyoung Hong, Jae Myung Yu, Hye Seung Jung, Bong-Soo Cha
  Diabetes & Metabolism Journal.2024; 48(5): 937.     CrossRef
• Cost-effectiveness and budget impact analysis of fixed combination of alogliptin and pioglitazone in the treatment of type 2 diabetes mellitus
  Yu.V. Strunina, N.A. Petunina
  Medical Technologies. Assessment and Choice.2023; (3): 70.     CrossRef
• Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice
  Piaojian Yu, Wei Wang, Wanrong Guo, Lidan Cheng, Zhiping Wan, Yanglei Cheng, Yunfeng Shen, Fen Xu
  Experimental and Clinical Endocrinology & Diabetes.2023; 131(11): 595.     CrossRef
• Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
  Joaquim Barreto, Beatriz Luchiari, Vaneza L. W. Wolf, Isabella Bonilha, Ticiane G. Bovi, Barbara S. Assato, Ikaro Breder, Sheila T. Kimura-Medorima, Daniel B. Munhoz, Thiago Quinaglia, Otavio R. Coelho-Filho, Luiz Sergio F. Carvalho, Wilson Nadruz, Andrei
  Diagnostics.2022; 12(4): 814.     CrossRef
• Effects of Glimepiride Combined with Recombinant Human Insulin Injection on Serum IGF-1, VEGF and TRACP-5b Oxidative Stress Levels in Patients with Type 2 Diabetes Mellitus
  Xue Chen, Sheng Kang, Zeqing Bao, Ciara Hughes
  Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
• Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
  Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
• Development and validation of a sensitive LC-MS/MS method for pioglitazone: application towards pharmacokinetic and tissue distribution study in rats
  Kusuma Kumari G., Praveen Thaggikuppe Krishnamurthy, Ravi Kiran Ammu V. V. V., Kurawattimath Vishwanath, S. T. Narenderan, B. Babu, Nagappan Krishnaveni
  RSC Advances.2021; 11(19): 11437.     CrossRef
• Compliance with Cardiovascular Prevention Guidelines in Individuals with Type 2 Diabetes in a Middle-Income Region: Cross-Sectional Analysis
  Joaquim Barreto, Beatriz Luchiari, Vaneza Lira W. Wolf, Isabella Bonilha, Ticiane G. Bovi, Barbara S. Assato, Ikaro Breder, Sheila T. Kimura-Medorima, Daniel B. Munhoz, Thiago Quinaglia, Otavio R. Coelho-Filho, Luiz Sérgio Fernandes de Carvalho, Wilson Na
  SSRN Electronic Journal .2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Current trends in solving the problem of residual cardiovascular risk
  N. Yu. Obedkova, A. A. Guslyakova, G. S. Mal, E. G. Obedkov
  Meditsinskiy sovet = Medical Council.2024; (6): 155.     CrossRef
• Association Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials
  Tianjiao Wang, Xin Zhang, Na Zhou, Yuxuan Shen, Biao Li, Bingshu E. Chen, Xinzhi Li
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• Nutraceutical support in the prevention and treatment of cardiovascular diseases
  E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka
  Rational Pharmacotherapy in Cardiology.2023; 19(3): 298.     CrossRef
• Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial
  Rehab H. Werida, Aalaa Ramzy, Youssri Nassief Ebrahim, Maged Wasfy Helmy
  BMC Endocrine Disorders.2023;[Epub]     CrossRef
• The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence
  Karla Paulina Luna-Castillo, Xochitl Citlalli Olivares-Ochoa, Rocío Guadalupe Hernández-Ruiz, Iris Monserrat Llamas-Covarrubias, Saraí Citlalic Rodríguez-Reyes, Alejandra Betancourt-Núñez, Barbara Vizmanos, Erika Martínez-López, José Francisco Muñoz-Valle
  Nutrients.2022; 14(5): 1104.     CrossRef
• The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of randomized controlled trials
  Yunjiao Yang, Wen Deng, Yanmei Wang, Tongyi Li, Yiding Chen, Cong Long, Qing Wen, Yue Wu, Qiu Chen
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Random
  Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, Kee Sik Kim, Moo Hyun Kim, Jun-Won Lee, Myung Ho Jeong, Jin-Ok Jeong, Jun-Hee Lee, Doo Soo Jeon, Eun Joo Cho, Soon Kil Kim, Jun Kwan, Chang Gyu Park, Hae Young Lee, Taek Jong Hong, Jinho Shin, Ho Joong Youn, Do
  Clinical Therapeutics.2021; 43(8): 1419.     CrossRef
• All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials
  Jeongseon Kim, Tung Hoang, Ji-Myung Kim, So Young Bu, Jeong-Hwa Choi, Eunju Park, Seung-Min Lee, Eunmi Park, Ji Yeon Min, In Seok Lee, So Young Youn, Jee-Young Yeon
  Nutrients.2020; 12(10): 3203.     CrossRef

Citations

Citations to this article as recorded by  

• Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population‐based study
  Xiangju Hu, Xin Fang, Minxia Wu
  Journal of Diabetes Investigation.2024; 15(8): 1034.     CrossRef
• Spline Longitudinal Multi-response Model for the Detection of Lifestyle- Based Changes in Blood Glucose of Diabetic Patients
  Anna Islamiyati
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes
  Han-sang Baek, Ji-Yeon Park, Jin Yu, Joonyub Lee, Yeoree Yang, Jeonghoon Ha, Seung Hwan Lee, Jae Hyoung Cho, Dong-Jun Lim, Hun-Sung Kim
  Endocrinology and Metabolism.2022; 37(4): 641.     CrossRef
• Agriophyllum Oligosaccharides Ameliorate Diabetic Insulin Resistance Through INS-R/IRS/Glut4-Mediated Insulin Pathway in db/db Mice and MIN6 Cells
  Shuyin Bao, Xiuzhi Wang, Sung Bo Cho, Yan-Ling Wu, Chengxi Wei, Shuying Han, Liming Bao, Qiong Wu, Wuliji Ao, Ji-Xing Nan
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Glycolipid metabolism and liver transcriptomic analysis of the therapeutic effects of pressed degreased walnut meal extracts on type 2 diabetes mellitus rats
  Yulan Li, Dan Chen, Chengmei Xu, Qingyujing Zhao, Yage Ma, Shenglan Zhao, Chaoyin Chen
  Food & Function.2020; 11(6): 5538.     CrossRef
• Cause-of-death statistics in 2018 in the Republic of Korea
  Hyun-Young Shin, Jin Kim, Seokmin Lee, Min Sim Park, Sanghee Park, Sun Huh
  Journal of the Korean Medical Association.2020; 63(5): 286.     CrossRef

Citations

Citations to this article as recorded by  

• The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases
  Xuepeng Bian, Qian Wang, Yibing Wang, Shujie Lou
  Frontiers in Molecular Neuroscience.2024;[Epub]     CrossRef
• A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes
  Gyuri Kim, Seohyun Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
  BMC Medicine.2024;[Epub]     CrossRef
• Exercise modalities for type 2 diabetes: A systematic review and network meta‐analysis of randomized trials
  Liangying Hou, Qi Wang, Bei Pan, Rui Li, Yanfei Li, Juanjuan He, Tianzhu Qin, Liujiao Cao, Na Zhang, Changhao Cao, Long Ge, Kehu Yang
  Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
• Estimating the Effect of Aerobic Exercise Training on Novel Lipid Biomarkers: A Systematic Review and Multivariate Meta-Analysis of Randomized Controlled Trials
  Gina Wood, Emily Taylor, Vanessa Ng, Anna Murrell, Aditya Patil, Tom van der Touw, Mitch Wolden, Nick Andronicos, Neil A. Smart
  Sports Medicine.2023; 53(4): 871.     CrossRef
• 2023 update on Italian guidelines for the treatment of type 2 diabetes
  Edoardo Mannucci, Riccardo Candido, Lina delle Monache, Marco Gallo, Andrea Giaccari, Maria Luisa Masini, Angela Mazzone, Gerardo Medea, Basilio Pintaudi, Giovanni Targher, Marina Trento, Giuseppe Turchetti, Valentina Lorenzoni, Matteo Monami
  Acta Diabetologica.2023; 60(8): 1119.     CrossRef
• The Effect of Eight Weeks of Concurrent Training on Serum Levels of Paraxonase-1, Irisin, Lipid Profile, and Insulin Resistance in Men With Metabolic Syndrome
  Seyed Amir Hosain Diba Hosaini, Morvarid Vafaee, Bahram Abedi
  Hormozgan Medical Journal.2023; 27(1): 43.     CrossRef
• An Overview of the TRP-Oxidative Stress Axis in Metabolic Syndrome: Insights for Novel Therapeutic Approaches
  Mizael C. Araújo, Suzany H. S. Soczek, Jaqueline P. Pontes, Leonardo A. C. Marques, Gabriela S. Santos, Gisele Simão, Laryssa R. Bueno, Daniele Maria-Ferreira, Marcelo N. Muscará, Elizabeth S. Fernandes
  Cells.2022; 11(8): 1292.     CrossRef
• Effect of Yijinjing combined with elastic band exercise on muscle mass and function in middle-aged and elderly patients with prediabetes: A randomized controlled trial
  Yunda Huang, Junhua Han, Qing Gu, Yanwei Cai, Jingyuan Li, Shasha Wang, Suijun Wang, Ru Wang, Xiangyun Liu
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Effect of combined aerobic and resistance exercise on blood pressure in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials
  Huihui Xi, Yayu He, Yirou Niu, Xin Sui, Jun Zhang, Ruiting Zhu, Haiyan Xu, Shuang Zhang, Yang Li, Yuan Yuan, Lirong Guo
  Experimental Gerontology.2021; 155: 111560.     CrossRef
• Effects of Augmented-Reality-Based Exercise on Muscle Parameters, Physical Performance, and Exercise Self-Efficacy for Older Adults
  Sangwan Jeon, Jiyoun Kim
  International Journal of Environmental Research and Public Health.2020; 17(9): 3260.     CrossRef
• Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity
  Ji A Seo, Min-Cheol Kang, Won-Mo Yang, Won Min Hwang, Sang Soo Kim, Soo Hyun Hong, Jee-In Heo, Achana Vijyakumar, Leandro Pereira de Moura, Aykut Uner, Hu Huang, Seung Hwan Lee, Inês S. Lima, Kyong Soo Park, Min Seon Kim, Yossi Dagon, Thomas E. Willnow, V
  Nature Communications.2020;[Epub]     CrossRef
• Impact of Skeletal Muscle Mass on Metabolic Health
  Gyuri Kim, Jae Hyeon Kim
  Endocrinology and Metabolism.2020; 35(1): 1.     CrossRef
• Habitual Combined Exercise Protects against Age-Associated Decline in Vascular Function and Lipid Profiles in Elderly Postmenopausal Women
  Elizabeth J. Pekas, John Shin, Won-Mok Son, Ronald J. Headid, Song-Young Park
  International Journal of Environmental Research and Public Health.2020; 17(11): 3893.     CrossRef

Citations

Citations to this article as recorded by  

• Type-2 Diabetes Alters Hippocampal Neural Oscillations and Disrupts Synchrony between the Hippocampus and Cortex
  Gratianne Rabiller, Zachary Ip, Shahram Zarrabian, Hongxia Zhang, Yoshimichi Sato, Azadeh Yazdan-Shahmorad, Jialing Liu
  Aging and disease.2024; 15(5): 2255.     CrossRef
• Unlocking the Protective Potential of Upper Respiratory Infection Treatment Histories against Alzheimer’s Disease: A Korean Adult Population Study
  Ho Suk Kang, Ji Hee Kim, Joo-Hee Kim, Woo Jin Bang, Hyo Geun Choi, Nan Young Kim, Ha Young Park, Mi Jung Kwon
  Journal of Clinical Medicine.2024; 13(1): 260.     CrossRef
• Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
  Francisco I. Pinheiro, Irami Araújo-Filho, Amália C.M. do Rego, Eduardo P. de Azevedo, Ricardo N. Cobucci, Fausto P. Guzen
  Ageing Research Reviews.2024; 96: 102250.     CrossRef
• Sex Differences in the Trajectories of Cognitive Decline and Affected Cognitive Domains Among Older Adults With Controlled and Uncontrolled Glycemia
  Natália Cochar-Soares, Dayane C de Oliveira, Mariane M Luiz, Márlon J R Aliberti, Claudia K Suemoto, Andrew Steptoe, Cesar de Oliveira, Tiago S Alexandre, Jay Magaziner
  The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.2024;[Epub]     CrossRef
• SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
  Hae Kyung Kim, Geert Jan Biessels, Min Heui Yu, Namki Hong, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Minyoung Lee
  Neurology.2024;[Epub]     CrossRef
• Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan
  Yu‐Hsin Yen, Fu‐Shun Yen, Fu‐Shun Ko, James Cheng‐Chung Wei, Yuhan Huang, Teng‐Shun Yu, Chii‐Min Hwu, Chih‐Cheng Hsu
  Diabetes, Obesity and Metabolism.2024; 26(11): 5399.     CrossRef
• Risk factors for the neurodegenerative dementias in the Western Pacific region
  Antonia J. Clarke, Amy Brodtmann, Muireann Irish, Loren Mowszowski, Kylie Radford, Sharon L. Naismith, Vincent C.T. Mok, Matthew C. Kiernan, Glenda M. Halliday, Rebekah M. Ahmed
  The Lancet Regional Health - Western Pacific.2024; 50: 101051.     CrossRef
• Machine Learning–Based Prediction of Neurodegenerative Disease in Patients With Type 2 Diabetes by Derivation and Validation in 2 Independent Korean Cohorts: Model Development and Validation Study
  Hyunji Sang, Hojae Lee, Jaeyu Park, Sunyoung Kim, Ho Geol Woo, Ai Koyanagi, Lee Smith, Sihoon Lee, You-Cheol Hwang, Tae Sun Park, Hyunjung Lim, Dong Keon Yon, Sang Youl Rhee
  Journal of Medical Internet Research.2024; 26: e56922.     CrossRef
• Amygdala activity and amygdala-hippocampus connectivity: Metabolic diseases, dementia, and neuropsychiatric issues
  Juhyun Song
  Biomedicine & Pharmacotherapy.2023; 162: 114647.     CrossRef
• The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021)
  Sunyoung Cho, Choon Ok Kim, Bong-soo Cha, Eosu Kim, Chung Mo Nam, Min-Gul Kim, Min Soo Park
  Diabetes Research and Clinical Practice.2023; 201: 110721.     CrossRef
• Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19
  Yoonkyung Chang, Jimin Jeon, Tae-Jin Song, Jinkwon Kim
  Heliyon.2023; 9(6): e17428.     CrossRef
• Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
  Wenhui Lei, Yiwen Cheng, Jie Gao, Xia Liu, Li Shao, Qingming Kong, Nengneng Zheng, Zongxin Ling, Weiming Hu
  Frontiers in Cellular and Infection Microbiology.2023;[Epub]     CrossRef
• The Association Between Eye Disease and Incidence of Dementia: Systematic Review and Meta-Analysis
  Jiayi Feng, Cuihong Huang, Lei Liang, Chuang Li, Xiaojie Wang, Jianping Ma, Xinhui Guan, Bin Jiang, Shaofen Huang, Pei Qin
  Journal of the American Medical Directors Association.2023; 24(9): 1363.     CrossRef
• Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study
  Hee-Cheol Kim, Ho-Jun Lee, Yang-Tae Kim, Byeong-Churl Jang, Asirvatham Alwin Robert
  Journal of Diabetes Research.2023; 2023: 1.     CrossRef
• Sarcopenia and diabetes-induced dementia risk
  Mingyang Sun, Zhongyuan Lu, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang
  Brain Communications.2023;[Epub]     CrossRef
• Association of periodontitis with microvascular complications of diabetes mellitus: A nationwide cohort study
  Moo-Seok Park, Jimin Jeon, Tae-Jin Song, Jinkwon Kim
  Journal of Diabetes and its Complications.2022; 36(2): 108107.     CrossRef
• Association between oral health and cardiovascular outcomes in patients with hypertension: a nationwide cohort study
  Jinkwon Kim, Hyung Jun Kim, Jimin Jeon, Tae-Jin Song
  Journal of Hypertension.2022; 40(2): 374.     CrossRef
• Diabetic retinopathy and cognitive dysfunction: a systematic review and meta-analysis
  Mei Wu, Fan Mei, Kaiyan Hu, Liyuan Feng, Zhe Wang, Qianqian Gao, Fei Chen, Li Zhao, Xiaohui Li, Bin Ma
  Acta Diabetologica.2022; 59(4): 443.     CrossRef
• Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis
  Yeng Yan Chow, Milou Verdonschot, Claire T. McEvoy, Geeske Peeters
  Diabetes Research and Clinical Practice.2022; 185: 109227.     CrossRef
• Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
  Rahnuma Ahmad, Kona Chowdhury, Santosh Kumar, Mohammed Irfan, Govindool Reddy, Farhana Akter, Dilshad Jahan, Mainul Haque
  Biology.2022; 11(3): 382.     CrossRef
• Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia
  Hee Kyung Kim, Juhyun Song
  International Journal of Molecular Sciences.2022; 23(6): 2982.     CrossRef
• Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis
  Athanasia Athanasaki, Konstantinos Melanis, Ioanna Tsantzali, Maria Ioanna Stefanou, Sofia Ntymenou, Sotirios G. Paraskevas, Theodosis Kalamatianos, Eleni Boutati, Vaia Lambadiari, Konstantinos I. Voumvourakis, George Stranjalis, Sotirios Giannopoulos, Ge
  Biomedicines.2022; 10(4): 778.     CrossRef
• Cardiometabolic measures and cognition in early menopause - Analysis of baseline data from a randomized controlled trial
  Lubna Pal, Kelly Morgan, Nanette F. Santoro, JoAnn E. Manson, Hugh S. Taylor, Virginia M. Miller, Eliot A. Brinton, Rogerio Lobo, Genevieve Neal-Perry, Marcelle I. Cedars, S. Mitchell Harman, Taryn T. James, Carey E. Gleason
  Maturitas.2022; 162: 58.     CrossRef
• Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
  Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
  International Journal of Molecular Sciences.2022; 23(17): 9540.     CrossRef
• Metabolically healthy obesity: it is time to consider its dynamic changes
  Yun Kyung Cho, Chang Hee Jung
  Cardiovascular Prevention and Pharmacotherapy.2022; 4(4): 123.     CrossRef
• Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
  You-Bin Lee, Min Young Kim, Kyungdo Han, Bongsung Kim, Jiyun Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
  Scientific Reports.2022;[Epub]     CrossRef
• The insulin resistance by triglyceride glucose index and risk for dementia: population-based study
  Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Alzheimer's Research & Therapy.2021;[Epub]     CrossRef
• The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA)
  Yebeen Ysabelle Boo, Otto-Emil Jutila, Meghan A. Cupp, Logan Manikam, Sung-Il Cho
  Aging Clinical and Experimental Research.2021; 33(9): 2573.     CrossRef
• Examining the effects of multiple chronic conditions on cognitive decline and potential moderators among older Koreans: Findings from the Korean Longitudinal Study of Ageing 2006–2016
  Yura Lee, Chi C. Cho
  Archives of Gerontology and Geriatrics.2021; 95: 104424.     CrossRef
• Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study
  Yunjung Cho, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
  Endocrinology and Metabolism.2021; 36(2): 424.     CrossRef
• Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus
  Tae-Jin Song, Jimin Jeon, Jinkwon Kim
  Diabetes & Metabolism.2021; 47(6): 101252.     CrossRef
• Association Between Diabetic Retinopathy and Cognitive Impairment: A Systematic Review and Meta-Analysis
  Dihe Cheng, Xue Zhao, Shuo Yang, Guixia Wang, Guang Ning
  Frontiers in Aging Neuroscience.2021;[Epub]     CrossRef
• Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
  Margherita Grasso, Giuseppe Caruso, Justyna Godos, Angela Bonaccorso, Claudia Carbone, Sabrina Castellano, Walter Currenti, Giuseppe Grosso, Teresa Musumeci, Filippo Caraci
  Antioxidants.2021; 10(7): 1075.     CrossRef
• The risk of Alzheimer’s disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study
  Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Joong-Yeol Park, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung
  Aging.2021; 13(13): 16974.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers
  Adriana Kubis-Kubiak, Aleksandra Dyba, Agnieszka Piwowar
  International Journal of Molecular Sciences.2020; 21(8): 2744.     CrossRef
• Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study
  Kyoung Hwa Lee, Da Eun Kwon, Kyung Do Han, Yeonju La, Sang Hoon Han
  BMC Neurology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Potential risk factors for mild cognitive impairment among patients with type 2 diabetes experiencing hypoglycemia
  Ruonan Gao, Menglan Zhan, Sujie Ke, Kejun Wu, Guanlian He, Liqin Qi, Xiaoying Liu, Xiaohong Liu, Lijing Wang, Libin Liu
  Diabetes Research and Clinical Practice.2024; 207: 111036.     CrossRef
• Association of hypoglycemic events with cognitive impairment in patients with type 2 diabetes mellitus: Protocol for a dose-response meta-analysis
  Min Ye, Ai Hong Yuan, Qi Qi Yang, Qun Wei Li, Fei Yue Li, Yan Wei, Muhammad Shahzad Aslam
  PLOS ONE.2024; 19(2): e0296662.     CrossRef
• AGE, DISEASE DURATION AND MULTIMORBIDITY AS PREDICTORS OF HYPOGLYCEMIA IN ELDERLY AND SENILE WOMEN WITH TYPE 2 DIABETES MELLITUS
  Polina Ya. Merzlova, Svetlana V. Bulgakova, Dmitry P. Kurmaev, Ekaterina V. Treneva
  Science and Innovations in Medicine.2024;[Epub]     CrossRef
• A nomogram for predicting the risk of cancer-related cognitive impairment in breast cancer patients based on a scientific symptom model
  Zhongtao Zhou, Jiajia Ren, Qiankun Liu, Shuoshuo Li, Jiahui Xu, Xiaoyan Wu, Yuanxiang Xiao, Zipu Zhang, Wanchen Jia, Huaiyu Bai, Jing Zhang
  Scientific Reports.2024;[Epub]     CrossRef
• Взаимосвязь гипогликемии и когнитивных нарушений у пожилых пациентов с сахарным диабетом 2 типа
  S. V. Bulgakova, P. Ya. Merzlova, D. P. Kurmaev, E. V. Treneva
  Russian Journal of Geriatric Medicine.2024; (2): 108.     CrossRef
• Effect of hypoglycemic events on cognitive function in individuals with type 2 diabetes mellitus: a dose–response meta-analysis
  Min Ye, Qiqi Yang, Lele Zhang, Hudie Song, Qin Fu, Jun Qian, Hongyu Xie, Aihong Yuan
  Frontiers in Neurology.2024;[Epub]     CrossRef
• Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling
  Wajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, Suzanne L Tyas, Iliana C Lega, John-Michael Gamble
  International Journal of Epidemiology.2023; 52(3): 908.     CrossRef
• Type 2 diabetes mellitus and cognitive function: understanding the connections
  Lisa Dao, Sarah Choi, Matthew Freeby
  Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(1): 7.     CrossRef
• Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
  Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie, Suzanne L. Tyas, Iliana C. Lega, John-Michael Gamble
  Diabetes Care.2023; 46(2): 331.     CrossRef
• Nocturnal hypoglycemia is underdiagnosed in older people with insulin‐treated type 2 diabetes: The HYPOAGE observational study
  Anne‐Sophie Boureau, Béatrice Guyomarch, Pierre Gourdy, Ingrid Allix, Cédric Annweiler, Nathalie Cervantes, Guillaume Chapelet, Isabelle Delabrière, Sophie Guyonnet, Rachel Litke, Marc Paccalin, Alfred Penfornis, Pierre‐Jean Saulnier, Matthieu Wargny, Sam
  Journal of the American Geriatrics Society.2023; 71(7): 2107.     CrossRef
• Dementia in Diabetes: The Role of Hypoglycemia
  Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler
  International Journal of Molecular Sciences.2023; 24(12): 9846.     CrossRef
• Association Between Trajectory of Severe Hypoglycemia and Dementia in Patients With Type 2 Diabetes: A Population-based Study
  Chung-Yi Li, Chia-Lun Kuo, Ya-Hui Chang, Chin-Li Lu, Santi Martini, Wen-Hsuan Hou
  Journal of Epidemiology.2022; 32(9): 423.     CrossRef
• Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study
  Eugene Han, Kyung-do Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): e1976.     CrossRef
• Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients
  Lifen Huang, Manlian Zhu, Jie Ji
  Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
• Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
  Sidharth Mehan, Sonalika Bhalla, Ehraz Mehmood Siddiqui, Nidhi Sharma, Ambika Shandilya, Andleeb Khan
  Degenerative Neurological and Neuromuscular Disease.2022; Volume 12: 31.     CrossRef
• Immortal time bias for life-long conditions in retrospective observational studies using electronic health records
  Freya Tyrer, Krishnan Bhaskaran, Mark J. Rutherford
  BMC Medical Research Methodology.2022;[Epub]     CrossRef
• Glucose-lowering drugs, cognition, and dementia: The clinical evidence
  Che-Yuan Wu, Lila Shapiro, Michael Ouk, Bradley J. MacIntosh, Sandra E. Black, Baiju R. Shah, Walter Swardfager
  Neuroscience & Biobehavioral Reviews.2022; 137: 104654.     CrossRef
• Switching insulin degludec to insulin glulisine improved nocturnal hypoglycemia and ventricular arrythmia in an elderly type 1 diabetes patient with chronic heart failure: A case report
  Yuriko Hajika, Yuji Kawaguchi, Takako Tanaka, Kenji Hamazaki, Yasuro Kumeda
  Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2022; 59(2): 237.     CrossRef
• Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
  Hanan Ehtewish, Abdelilah Arredouani, Omar El-Agnaf
  International Journal of Molecular Sciences.2022; 23(11): 6144.     CrossRef
• Amyloid $$upbeta$$ (1–42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence
  Siva S. V. P. Sakamuri, Venkata N. Sure, Xiaoying Wang, Gregory Bix, Vivian A. Fonseca, Ricardo Mostany, Prasad V. G. Katakam
  GeroScience.2022; 44(6): 2721.     CrossRef
• Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
  Premranjan Kumar, Jayshree Mishra, Narendra Kumar
  Nutrients.2022; 14(18): 3715.     CrossRef
• Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes?
  Clémence Bussiere, Pauline Chauvin, Jean-Michel Josselin, Christine Sevilla-Dedieu
  Health Economics Review.2022;[Epub]     CrossRef
• Fasting Glucose Variability and the Risk of Dementia in Individuals with Diabetes: A Nationwide Cohort Study
  Da Young Lee, Jaeyoung Kim, Sanghyun Park, So Young Park, Ji Hee Yu, Ji A Seo, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Kyungdo Han, Nan Hee Kim
  Diabetes & Metabolism Journal.2022; 46(6): 923.     CrossRef
• Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
  Katharina Mattishent, Yoon K. Loke
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
  Olga V. Saik, Vadim V. Klimontov
  International Journal of Molecular Sciences.2021; 22(22): 12419.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Optimal Type 2 Diabetes Mellitus Management and Active Ageing
  Alessia Maria Calabrese, Valeria Calsolaro, Sara Rogani, Chukwuma Okoye, Nadia Caraccio, Fabio Monzani
  Endocrines.2021; 2(4): 523.     CrossRef
• Response: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Seung Jin Han
  Diabetes & Metabolism Journal.2020; 44(2): 360.     CrossRef
• Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
  Francesco Zaccardi, Suping Ling, Claire Lawson, Melanie J. Davies, Kamlesh Khunti
  Diabetologia.2020; 63(10): 2129.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• Low‐glucose‐sensitive TRPC6 dysfunction drives hypoglycemia‐induced cognitive impairment in diabetes
  Chengkang He, Peng Gao, Yuanting Cui, Qiang Li, Yingsha Li, Zongshi Lu, Huan Ma, Yu Zhao, Li Li, Fang Sun, Xiaowei Chen, Hongbo Jia, Daoyan Liu, Gangyi Yang, Hongting Zheng, Zhiming Zhu
  Clinical and Translational Medicine.2020;[Epub]     CrossRef
• Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
  Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian, Dimitri P. Mikhailidis
  Current Pharmaceutical Design.2020; 26(43): 5637.     CrossRef

Citations

Citations to this article as recorded by  

• The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
  Kamila Puchałowicz, Monika Ewa Rać
  Cells.2020; 9(8): 1877.     CrossRef
• The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond
  Jun Sung Moon, Udayakumar Karunakaran, Elumalai Suma, Seung Min Chung, Kyu Chang Won
  Diabetes & Metabolism Journal.2020; 44(2): 222.     CrossRef

Citations

Citations to this article as recorded by  

• Anti-obesogenic effects of plant natural products: A focus on Korean traditional foods
  Gitishree Das, Luis Alfonso Jiménez Ortega, Sandra Gonçalves, J. Basilio Heredia, Maria de Lourdes Gomes Pereira, Anabela Romano, Han-Seung Shin, Jayanta Kumar Patra
  Trends in Food Science & Technology.2024; : 104470.     CrossRef
• Sex differences in waist circumference obesity and eating speed: a cross-sectional study of Japanese people with normal body mass index
  Yuri Yaguchi, Tsuneo Konta, Nahomi Imaeda, Chiho Goto, Yoshiyuki Ueno, Takamasa Kayama
  Frontiers in Nutrition.2024;[Epub]     CrossRef
• Association of Dietary Patterns with Metabolic Syndrome in Chinese Children and Adolescents Aged 7–17: The China National Nutrition and Health Surveillance of Children and Lactating Mothers in 2016–2017
  Jia Shi, Hongyun Fang, Qiya Guo, Dongmei Yu, Lahong Ju, Xue Cheng, Wei Piao, Xiaoli Xu, Zizi Li, Di Mu, Liyun Zhao, Li He
  Nutrients.2022; 14(17): 3524.     CrossRef
• What Is the Relationship between Antioxidant Efficacy, Functional Composition, and Genetic Characteristics in Comparing Soybean Resources by Year?
  Han-Na Chu, Suji Lee, Xiaohan Wang, Chi-Do Wee, Hye-Myeong Yoon, Eun-Suk Jung, Mi-Kyung Seo, Yongseok Kwon, Kyeong-A Jang, Haeng-Ran Kim
  Antioxidants.2022; 11(11): 2249.     CrossRef
• Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study
  Andrea J. Glenn, Pablo Hernández-Alonso, Cyril W.C. Kendall, Miguel Ángel Martínez-González, Dolores Corella, Montserrat Fitó, J.Alfredo Martínez, Ángel M. Alonso-Gómez, Julia Wärnberg, Jesús Vioque, Dora Romaguera, José López-Miranda, Ramon Estruch, Fran
  Clinical Nutrition.2021; 40(5): 2825.     CrossRef
• The Effects of Dietary Pattern on Metabolic Syndrome in Jiangsu Province of China: Based on a Nutrition and Diet Investigation Project in Jiangsu Province
  Yuanyuan Wang, Yue Dai, Ting Tian, Jingxian Zhang, Wei Xie, Da Pan, Dengfeng Xu, Yifei Lu, Shaokang Wang, Hui Xia, Guiju Sun
  Nutrients.2021; 13(12): 4451.     CrossRef
• Sex-Specific Energy Intakes and Physical Activity Levels According to the Presence of Metabolic Syndrome in Korean Elderly People: Korean National Health and Nutrition Examination Survey 2016–2018
  Won-Sang Jung, Hun-Young Park, Sung-Woo Kim, Kiwon Lim
  International Journal of Environmental Research and Public Health.2020; 17(15): 5416.     CrossRef

Citations

Citations to this article as recorded by  

• Epithelial–mesenchymal plasticity in kidney fibrosis
  Sudarat Hadpech, Visith Thongboonkerd
  genesis.2024;[Epub]     CrossRef
• Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway
  Wenhui Zhong, Yuheng Jiang, Huizhen Wang, Xiang Luo, Tao Zeng, Huimi Huang, Ling Xiao, Nan Jia, Aiqing Li
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119620.     CrossRef
• Platelet concentrates may affect the formation of pathological scars by regulating epithelial to mesenchymal transition
  Ju Tian, Dandan Shi, Chenyan Long, Jing Ding, Huimin You, Xiaoying He, Biao Cheng
  Medical Hypotheses.2024; 182: 111227.     CrossRef
• Cadherin-responsive hydrogel combined with dental pulp stem cells and fibroblast growth factor 21 promotes diabetic scald repair via regulating epithelial-mesenchymal transition and necroptosis
  Wenjie Lu, Juan Zhao, Xiong Cai, Yutian Wang, Wenwei Lin, Yaoping Fang, Yunyang Wang, Jinglei Ao, Jiahui Shou, Jiake Xu, Sipin Zhu
  Materials Today Bio.2024; 24: 100919.     CrossRef
• Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating the tight junctions of renal tubular epithelial cells
  Tingting Yang, Lin Li, Cai Heng, Pian Sha, Yiying Wang, Jiaming Shen, Zhenzhou Jiang, Sitong Qian, Chujing Wei, Hao Yang, Xia Zhu, Tao Wang, Mengying Wu, Jianyun Wang, Qian Lu, Xiaoxing Yin
  Food & Function.2024; 15(5): 2628.     CrossRef
• Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
  Anton I. Korbut, Vyacheslav V. Romanov, Vadim V. Klimontov
  Biomedicines.2024; 12(3): 487.     CrossRef
• FGF21 Inhibits Hypoxia/Reoxygenation-induced Renal Tubular Epithelial Cell Injury by Regulating the PPARγ/NF-κB Signaling Pathway
  Ruixue Li, Xi Liu
  Cell Biochemistry and Biophysics.2024; 82(2): 909.     CrossRef
• Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells
  Shivam Rajput, Rishabha Malviya, Prerna Uniyal
  Current Pharmaceutical Design.2024; 30(11): 825.     CrossRef
• The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
  Mada Ghanem, Gabrielle Archer, Bruno Crestani, Arnaud A. Mailleux
  Pharmacology & Therapeutics.2024; 259: 108669.     CrossRef
• Elevation of p53 sensitizes obese kidney to adriamycin-induced aberrant lipid homeostasis via repressing HNF4α-mediated FGF21 sensitivity
  Jiahao Li, Yufeng Tang, Guangping Lu, Qingbo Liu, Yuanfang Guo, Jie Wang, Mengjie Xiao, Ting Gao, Xiaohui Zhang, Junlian Gu
  Journal of Advanced Research.2024;[Epub]     CrossRef
• Gemigliptin mitigates TGF-β-induced renal fibrosis through FGF21-mediated inhibition of the TGF-β/Smad3 signaling pathway
  Jun-Kyu Byun, Gwon-Soo Jung
  Biochemical and Biophysical Research Communications.2024; 733: 150425.     CrossRef
• Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication
  Hui Wang, Shanshan Guo, Huanqing Gao, Jiyang Ding, Hongyun Li, Xingyu Kong, Shuang Zhang, Muyang He, Yonghao Feng, Wei Wu, Kexin Xu, Yuxuan Chen, Hanyin Zhang, Tiemin Liu, Xingxing Kong
  Journal of Clinical Investigation.2024;[Epub]     CrossRef
• Timosaponin BII inhibits TGF‐β mediated epithelial‐mesenchymal transition through Smad‐dependent pathway during pulmonary fibrosis
  Dali Ding, Xuebin Shen, Lizhen Yu, Yueyue Zheng, Yao Liu, Wei Wang, Li Liu, Zitong Zhao, Sihui Nian, Limin Liu
  Phytotherapy Research.2023; 37(7): 2787.     CrossRef
• Fibroblast growth factors (FGFs) endocrines et fibrogenèse pulmonaire
  M. Ghanem, A. Mailleux, B. Crestani
  Revue des Maladies Respiratoires.2023; 40(3): 239.     CrossRef
• Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
  Fukun Chen, NaNa Chen, Chunjuan Xia, Hongyue Wang, Lishi Shao, Chen Zhou, Jiaping Wang
  Cell Transplantation.2023; 32: 096368972311642.     CrossRef
• MicroRNA functional metal-organic framework nanocomposite for efficient inhibition of drug-resistant breast cancer cells
  Yuxin Shen, Yao Zhang, Xiyue Gao, Mengdi Shang, Yanfei Cai, Zhaoqi Yang
  Emergent Materials.2023; 6(5): 1537.     CrossRef
• Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1
  Yingying Chen, Zhong He, Bo Zhao, Rui Zheng
  Cellular Signalling.2023; 109: 110795.     CrossRef
• KLF5/MDM2 Axis Modulates Oxidative Stress and Epithelial-Mesenchymal Transition in Human Lens Epithelial Cells: The Role in Diabetic Cataract
  Xiao Li, Doudou Chen, Bowen Ouyang, Shengnan Wang, Yawei Li, Li Li, Siquan Zhu, Guangying Zheng
  Laboratory Investigation.2023; 103(11): 100226.     CrossRef
• MAP3K19 Promotes the Progression of Tuberculosis-Induced Pulmonary Fibrosis Through Activation of the TGF-β/Smad2 Signaling Pathway
  Yu Xia, Haiyue Wang, Meihua Shao, Xuemei Liu, Feng Sun
  Molecular Biotechnology.2023;[Epub]     CrossRef
• Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA
  LiSha He, Tingting Bao, Yingying Yang, Han Wang, Chengjuan Gu, Jia Chen, Tiangang Zhai, Xinhui He, Mengyi Wu, Linhua Zhao, Xiaolin Tong
  Journal of Ethnopharmacology.2022; 285: 114786.     CrossRef
• Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats
  Chan Gao, Xiao Fei, Ming Wang, Qi Chen, Ning Zhao
  International Immunopharmacology.2022; 107: 108610.     CrossRef
• Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
  Guihai Wu, Shenglin Wu, Jingyi Yan, Shanshan Gao, Jinxiu Zhu, Minghui Yue, Zexin Li, Xuerui Tan
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
  Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou, Liang-Jun Yan
  Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
• Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the regulation of miR-508-3p/SMAD family member 2 pathway
  Mingqun Li, Yuqin Huang, Hongli Xi, Wei Zhang, Ziwu Xiang, Lingyun Wang, Xuanyu Li, Hongyan Guo
  Endocrine Journal.2022; 69(9): 1067.     CrossRef
• Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress
  Xinghao Jiang, Qing Wu, Yeboah Kwaku Opoku, Yimeng Zou, Dan Wang, Changhui Hu, Guiping Ren
  Basic & Clinical Pharmacology & Toxicology.2022; 131(6): 474.     CrossRef
• Myokines: Novel therapeutic targets for diabetic nephropathy
  Ming Yang, Shilu Luo, Jinfei Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk
  Songling Jiang, Dal-Seok Oh, Debra Dorotea, Eunjung Son, Dong-Seon Kim, Hunjoo Ha
  Phytomedicine.2021; 80: 153393.     CrossRef
• Chromatin accessibility of kidney tubular cells under stress reveals key transcription factor mediating acute and chronic kidney disease
  Yuexian Xing, Qi Wang, Jing Zhang, Wenju Li, Aiping Duan, Jingping Yang, Zhihong Liu
  The FEBS Journal.2021; 288(18): 5446.     CrossRef
• Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy
  Ya-long Feng, Wen-bo Wang, Yue Ning, Hua Chen, Pei Liu
  Biomedicine & Pharmacotherapy.2021; 139: 111386.     CrossRef
• FGF21 prevents low-protein diet-induced renal inflammation in aged mice
  Han Fang, Sujoy Ghosh, Landon C. Sims, Kirsten P. Stone, Cristal M. Hill, Denisha Spires, Daria V. Ilatovskaya, Christopher D. Morrison, Thomas W. Gettys, Krisztian Stadler
  American Journal of Physiology-Renal Physiology.2021; 321(3): F356.     CrossRef
• IFN-α-2b Inhibits the Proliferation and Migration of Fibroblasts via the TGFβ/Smad Signaling Pathway to Reduce Postoperative Epidural Fibrosis
  Zhendong Liu, Hui Chen, Zhehao Fan, Jihang Dai, Yu Sun, Lianqi Yan, Rui Wang, Xiaolei Li, Jingcheng Wang
  Journal of Interferon & Cytokine Research.2021; 41(8): 271.     CrossRef
• FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma
  Chaojia Wang, Hanjun Tu, Ling Yang, Chunming Ma, Juntao Hu, Jie Luo, Hui Wang
  Aging.2021; 13(17): 21587.     CrossRef
• Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease
  Xue Zhou, Yuefeng Zhang, Ning Wang
  Frontiers in Physiology.2021;[Epub]     CrossRef
• The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
  Junyu Deng, Ye Liu, Yiqiu Liu, Wei Li, Xuqiang Nie
  Journal of Inflammation Research.2021; Volume 14: 5273.     CrossRef
• Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction
  Yixuan Ma, Yixin Kuang, Wenyan Bo, Qiaoqin Liang, Wenfei Zhu, Mengxin Cai, Zhenjun Tian
  International Journal of Molecular Sciences.2021; 22(22): 12341.     CrossRef
• Snai1-induced partial epithelial–mesenchymal transition orchestrates p53–p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated inflammation
  Ruochen Qi, Jiyan Wang, Yamei Jiang, Yue Qiu, Ming Xu, Ruiming Rong, Tongyu Zhu
  Cell Death & Disease.2021;[Epub]     CrossRef
• Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation
  Ping Sun, Ning Xu, Yan Li, Yang Han
  International Immunopharmacology.2020; 85: 106686.     CrossRef

• Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway

  
  Chuan Guo, Yarong Wang, Yuanlin Piao, Xiangrong Rao, Dehai Yin
  Drug Design, Development and Therapy.2020; Volume 14: 4951.     CrossRef